HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib
Authors
Keywords
-
Journal
BLOOD
Volume 127, Issue 25, Pages 3237-3252
Publisher
American Society of Hematology
Online
2016-05-04
DOI
10.1182/blood-2016-01-695098

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.